Sleeve resection after neoadjuvant chemoimmunotherapy in the treatment of locally advanced non-small cell lung cancer
Jie Dai(Tongji University), Gening Jiang(Tongji University), Mara B. Antonoff(The University of Texas MD Anderson Cancer Center), Wenxin He(Tongji University), Deping Zhao(Second Military Medical University), Xinsheng Zhu(Tongji University), Liang Duan(Dalian Medical University), Robert A. Ramirez(Vanderbilt University Medical Center), Mariano Provencio(Hospital Universitario Puerta de Hierro Majadahonda), Xiaogang Liu(Tongji University), Chang Chen(First Hospital of Lanzhou University), Chunyan Wu(Shanghai Pulmonary Hospital), Dianke Li(Shanghai Pulmonary Hospital), Yan Huang(Shanghai Pulmonary Hospital), Yuming Zhu(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 19
Related Papers
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
|The Lancet Oncology|2012|5.5k
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
|New England Journal of Medicine|2009|2.4k
Development and validation of a deep-learning algorithm for the detection of polyps during colonoscopy
|Nature Biomedical Engineering|2018|491
Effect of a deep-learning computer-aided detection system on adenoma detection during colonoscopy (CADe-DB trial): a double-blind randomised study
|The Lancet. Gastroenterology & hepatology|2020|404